Personality disorders and treatment outcome in methadone maintenance patients

The Journal of Nervous and Mental Disease
J S CacciolaE C Snider

Abstract

This study examined the relationship between personality disorder (PDs) and 7-month treatment outcome in 197 men admitted to methadone maintenance. Subjects reported pervasive improvement, and the amount of improvement did not significantly differ for those subjects with and without PDs. PD subjects entered treatment with more severe self-reported drug, alcohol, psychiatric, and legal problems, and despite progress, remained more problematic in those areas relative to subjects without PDs. Subjects with antisocial PD had admission and 7-month problem status similar to subjects with other PDs. The 7-month urinalysis results for opiates and cocaine showed no significant differences between subjects with and without PDs. Fewer PD subjects stayed in treatment continuously for the 7-month period. Several cluster B PDs-borderline, antisocial, and histrionic-predicted poorest overall outcomes. Methadone-maintained patients with PDs may warrant additional treatment services if they are to approach the functional level of patients without PDs.

References

Jul 1, 1991·The Journal of Nervous and Mental Disease·A I Alterman, J S Cacciola
Feb 1, 1991·The Journal of Nervous and Mental Disease·J H Reich, A I Green
Mar 1, 1991·Acta Psychiatrica Scandinavica·H J JacksonJ Edwards
Jan 1, 1989·Journal of Substance Abuse Treatment·T A KostenB J Rounsaville
Jun 1, 1987·Archives of General Psychiatry·B J RounsavilleR E Meyer
May 1, 1986·Journal of Studies on Alcohol·E P NaceN Shore
Jul 1, 1985·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Nov 1, 1985·Archives of General Psychiatry·E J Khantzian, C Treece
Feb 1, 1982·Archives of General Psychiatry·B J RounsavilleC Wilber
Nov 1, 1982·Comprehensive Psychiatry·T R KostenH D Kleber
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Mar 1, 1995·The Journal of Nervous and Mental Disease·J S CacciolaE C Snider
Mar 1, 1994·Drug and Alcohol Dependence·M J RutherfordA I Alterman
Mar 1, 1994·Archives of General Psychiatry·M Zimmerman
May 1, 1993·Comprehensive Psychiatry·R D WeissC Hufford
Apr 21, 1993·JAMA : the Journal of the American Medical Association·A T McLellanC P O'Brien

❮ Previous
Next ❯

Citations

Nov 5, 1998·Addictive Behaviors·R VerheulC Hartgers
Feb 13, 2001·Drug and Alcohol Dependence·J S CacciolaF D Mulvaney
Apr 12, 2000·Drug and Alcohol Dependence·W M ComptonE L Spitznagel
Sep 27, 2003·Journal of Substance Abuse Treatment·Gilberto GerraEmilio Sternieri
Jul 18, 2003·Journal of Substance Abuse Treatment·George T Ladd, Nancy M Petry
Feb 15, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·K Tómasson, P Vaglum
Aug 22, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·R Verheul
Aug 11, 2004·Journal of Consulting and Clinical Psychology·Samuel A BallKathleen M Carroll
Sep 17, 2004·Journal of Psychoactive Drugs·Marlene StenbackaLouise Lettholm
Jun 1, 1997·The Journal of Nervous and Mental Disease·M A Blais
Feb 11, 1998·The Journal of Nervous and Mental Disease·R S SchottenfeldT R Kosten
May 6, 2011·The Journal of Nervous and Mental Disease·Samuel A BallMark J Ostrowski
Jan 19, 1999·Journal of Personality Disorders·J S CacciolaF D Mulvaney
Mar 29, 2014·Comprehensive Psychiatry·Wei-Lieh HuangYu-Hsuan Lin
Aug 18, 2010·Psychological Reports·Elena Fernandez Del RíoElisardo Becoña
Apr 28, 2012·Journal of Substance Abuse Treatment·Joseph CoxChris Small
Dec 14, 2011·Addictive Behaviors·Marsha N SargeantCarl W Lejuez
Jun 19, 2007·Journal of Substance Abuse Treatment·Patrick M Flynn, Barry S Brown
Jun 19, 2007·Journal of Substance Abuse Treatment·Karin J NeufeldRobert K Brooner
Nov 29, 2005·Journal of Substance Abuse Treatment·Anja Dobler-MikolaJiri Modestin
Aug 23, 2008·Drug and Alcohol Dependence·Stephen F ButlerAlbert Villapiano
Sep 13, 2011·Drug and Alcohol Dependence·Matthew T Tull, Kim L Gratz
Mar 7, 2017·Journal of Personality Disorders·Dominick GamacheEvens Villeneuve
May 26, 2012·Journal of Psychopharmacology·A R Lingford-HughesUNKNOWN British Association for Psychopharmacology, Expert Reviewers Group
Sep 7, 2006·International Journal of Geriatric Psychiatry·S P J van AlphenJ J L Derksen
May 15, 2010·The American Journal of Drug and Alcohol Abuse·Michael MancinoBrenda M Booth
Aug 17, 2001·The American Journal of Drug and Alcohol Abuse·R B GoldsteinS I Powers
Nov 16, 2004·The American Journal of Drug and Alcohol Abuse·David TeplinMichael Varenbut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.